| Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure G Gourzoulidis, G Kourlaba, P Stafylas, G Giamouzis, J Parissis, ... Health Policy 121 (4), 363-377, 2017 | 59 | 2017 |
| Cost-effectiveness of empagliflozin for the treatment of patients with type 2 diabetes mellitus at increased cardiovascular risk in Greece G Gourzoulidis, C Tzanetakos, I Ioannidis, A Tsapas, G Kourlaba, ... Clinical Drug Investigation 38, 417-426, 2018 | 42 | 2018 |
| Indicators to assess physiological heat strain–Part 3: Multi-country field evaluation and consensus recommendations LG Ioannou, L Tsoutsoubi, K Mantzios, M Vliora, E Nintou, JF Piil, ... Temperature 9 (3), 274-291, 2022 | 32 | 2022 |
| Cost effectiveness of exenatide once weekly versus insulin glargine and liraglutide for the treatment of type 2 diabetes mellitus in Greece C Tzanetakos, A Bargiota, G Kourlaba, G Gourzoulidis, N Maniadakis Clinical drug investigation 38, 67-77, 2018 | 18 | 2018 |
| Cost-effectiveness analysis of rivaroxaban for treatment of deep vein thrombosis and pulmonary embolism in Greece G Gourzoulidis, G Kourlaba, J Kakisis, M Matsagkas, G Giannakoulas, ... Clinical Drug Investigation 37, 833-844, 2017 | 16 | 2017 |
| Indicators to assess physiological heat strain–Part 2: Delphi exercise LG Ioannou, PC Dinas, SR Notley, F Gofa, GA Gourzoulidis, M Brearley, ... Temperature 9 (3), 263-273, 2022 | 13 | 2022 |
| Do self-perceptions of emotional intelligence predict health-related quality of life? A case study in hospital managers in Greece G Gourzoulidis, N Kontodimopoulos, C Kastanioti, T Bellali, K Goumas, ... Global journal of health science 7 (1), 210, 2015 | 12 | 2015 |
| PNS61 does a standard willingness-to-pay threshold exist in Greece? C Tzanetakos, G Stefanou, G Gourzoulidis Value in Health 22, S772-S773, 2019 | 11 | 2019 |
| Economic evaluation of trifluridine and tipiracil hydrochloride in the treatment of metastatic colorectal cancer in Greece G Gourzoulidis, N Maniadakis, D Petrakis, J Souglakos, ... Journal of comparative effectiveness research 8 (3), 133-142, 2018 | 11 | 2018 |
| Does a standard cost-effectiveness threshold exist? The case of Greece C Tzanetakos, G Gourzoulidis Value in Health Regional Issues 36, 18-26, 2023 | 10 | 2023 |
| Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece K Vellopoulou, G Stefanou, C Tzanetakos, N Boubouchairopoulou, ... European Journal of Gastroenterology & Hepatology 33 (3), 325-333, 2021 | 10 | 2021 |
| Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study G Kourlaba, C Vlachopoulos, J Parissis, J Kanakakis, G Gourzoulidis, ... BMC health services research 15, 1-9, 2015 | 9 | 2015 |
| Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients … G Gourzoulidis, M Koulentaki, A Koumarianou, E Samadas, ... Expert review of pharmacoeconomics & outcomes research 22 (2), 259-269, 2022 | 8 | 2022 |
| Cost-effectiveness of Empagliflozin compared with Dapagliflozin for the treatment of patients with type 2 diabetes mellitus and established cardiovascular disease in Greece G Gourzoulidis, C Tzanetakos, I Ioannidis, V Tsimihodimos, V Diogo, ... Clinical Drug Investigation 41, 371-380, 2021 | 6 | 2021 |
| The Cost-Effectiveness of Nanoliposomal Irinotecan and 5-Fluorouracil (5-FU)/Leucovorin (LV) for the Treatment of Patients With Metastatic Adenocarcinoma of Pancreas Who Have … G Gourzoulidis Poster presented at the Virtual International Society for Pharmacoeconomics …, 2020 | 6 | 2020 |
| PCN108 the cost-effectiveness of liposomal irinotecan and 5-fluorouracil (5-FU)/leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of pancreas who … G Gourzoulidis, G Stefanou, M Koulentaki, A Beletsi, I Boukovinas, ... Value in Health 23, S442, 2020 | 5 | 2020 |
| Economic evaluation of trimetazidine in the management of chronic stable angina in Greece G Kourlaba, G Gourzoulidis, G Andrikopoulos, K Tsioufis, A Beletsi, ... BMC Health Services Research 16, 1-8, 2016 | 5 | 2016 |
| Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants S Warren, M Barmpouni, V Kossyvaki, G Gourzoulidis, J Perdrizet Vaccines 11 (8), 1369, 2023 | 4 | 2023 |
| End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study E Kokkotou, G Stefanou, N Syrigos, G Gourzoulidis, E Ntalakou, ... Journal of Comparative Effectiveness Research 10 (4), 315-324, 2021 | 4 | 2021 |
| Health and Economic outcomes of 20-Valent Pneumococcal Conjugate Vaccine compared to 15-Valent Pneumococcal Conjugate Vaccine Strategies for adults in Greece. G Gourzoulidis, M Barmpouni, V Kossyvaki, J Vietri, C Tzanetakos Frontiers in Public Health 11, 1229524, 2023 | 3 | 2023 |
